The Psychedelic Investment Opportunity

Mar 16, 2022

2:30pm – 3:30pm CT

Recording: The Psychedelic Investment Opportunity, Mar 16, 2022

The Psychedelic Investment Opportunity: Separating the Posers from the Pioneers
Psilocybin, ketamine, MDMA, LSD and mescaline are creating a new paradigm in wellbeing, and investors are taking notice. With the inflection point for psychedelic science here, savvy investors are eager to weed out the posers from the pioneers, particularly given the rapid rate at which the regulatory landscape, cultural attitudes and research are evolving. But, fear not. We’ve assembled some of the brightest financial minds from across the psychedelic ecosystem to help you easily distinguish get-rich-quick schemes from actionable investment opportunities.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.

Debra Borchardt

Green Market Report

Daniel Goldberg

Palo Santo VC Fund

Ronan Levy

Field Trip Health

Gregg Peterson

Bexson Biomedical

This event will be in person

Details

Primary Entry:
Platinum Badge
Interactive Badge
Secondary Entry:
Music Badge
Film Badge
Format:

Panel

Type:

Session

Track:

Health & MedTech track sponsored by Optum

Summit:

The State of Psychedelics summit sponsored by Vine VC

Level:

Intermediate